Pharmaceutical Development

Drug Screening

Screening of drug candidates

SAXOCON provides a range of computer-based models to identify structural alerts and predict biological effects so that you can predictively screen for new active substances, which is key to successful drug discovery.

PRODUCT SHEET

Impurities

Impurities safety evaluation

SAXOCON can help you to establish and document Permitted Daily Exposure (PDE) and establish limits for impurities to ensure the quality and safety your product in accordance with regulatory requirements.

PRODUCT SHEET

primary packaging

Primary packaging safety assurance

SAXOCON helps you to establish and document compliance for your containers and other primary packaging systems with all relevant regulatory requirements. Thus ensuring the safety and quality of the finished product.

PRODUCT SHEET